Business Description
Resonance Health Ltd
ISIN : AU000000RHT2
Total Employee Number:
18Description
Resonance Health Ltd is engaged in the development and commercialisation of software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. The Group's core SaMD product is FerriScan, a non-invasive liver analysis technology used for the assessment of iron in the liver. The Company also has several AI-assisted SaMDs including FerriSmart, HepaFatSmart, and LiverSmart. Its business segments are; SaMD1 which derives key revenue, Corporate, TrialsWest, and Resonance Clinica. Geographically, it generates maximum revenue from the Asia Pacific region and the rest from North America, and Europe, Middle East and Africa (EMEA) regions.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.66 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.37 | |||||
Debt-to-EBITDA | 2.69 | |||||
Interest Coverage | 1.96 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -3.31 | |||||
Beneish M-Score | -2.81 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 44.2 | |||||
3-Year EBITDA Growth Rate | 12.6 | |||||
3-Year EPS without NRI Growth Rate | -10.1 | |||||
3-Year Book Growth Rate | -4.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 59.77 | |||||
9-Day RSI | 59.92 | |||||
14-Day RSI | 58.14 | |||||
6-1 Month Momentum % | -9.09 | |||||
12-1 Month Momentum % | 17.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.87 | |||||
Quick Ratio | 1.87 | |||||
Cash Ratio | 0.77 | |||||
Days Sales Outstanding | 82.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | -1.22 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | 4.74 | |||||
Net Margin % | 5.56 | |||||
EBITDA Margin % | 10.87 | |||||
FCF Margin % | -1.11 | |||||
OCF Margin % | 3.04 | |||||
ROE % | 7.6 | |||||
ROA % | 4.29 | |||||
ROIC % | 4.57 | |||||
3-Year ROIIC % | -1.97 | |||||
ROC (Joel Greenblatt) % | 30.41 | |||||
ROCE % | 4.09 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 46 | |||||
PE Ratio without NRI | 46 | |||||
PS Ratio | 1.54 | |||||
PB Ratio | 2.01 | |||||
Price-to-Free-Cash-Flow | 46 | |||||
Price-to-Operating-Cash-Flow | 46 | |||||
EV-to-EBIT | 40.64 | |||||
EV-to-EBITDA | 14.86 | |||||
EV-to-Revenue | 1.61 | |||||
EV-to-FCF | -158.57 | |||||
Price-to-GF-Value | 0.38 | |||||
Price-to-Projected-FCF | 1.53 | |||||
Price-to-Median-PS-Value | 0.31 | |||||
Earnings Yield (Greenblatt) % | 2.46 | |||||
FCF Yield % | -0.73 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Resonance Health Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 13.838 | ||
| EPS (TTM) (A$) | 0.001 | ||
| Beta | 1.3379 | ||
| 3-Year Sharpe Ratio | 0.18 | ||
| 3-Year Sortino Ratio | 0.29 | ||
| Volatility % | 36.95 | ||
| 14-Day RSI | 58.14 | ||
| 14-Day ATR (A$) | 0.001942 | ||
| 20-Day SMA (A$) | 0.0422 | ||
| 12-1 Month Momentum % | 17.65 | ||
| 52-Week Range (A$) | 0.033 - 0.059 | ||
| Shares Outstanding (Mil) | 477.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Resonance Health Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Resonance Health Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2003-10-15 | 0.17 (+10.00%) | ||
| 0.153846:1 Stock Split | 2002-10-21 | -- | ||
| 5:1 Stock Split | 1994-04-21 | -- |
Show
Entries
Resonance Health Ltd Frequently Asked Questions
What is Resonance Health Ltd(ASX:RHT)'s stock price today?
The current price of ASX:RHT is A$0.05. The 52 week high of ASX:RHT is A$0.06 and 52 week low is A$0.03.
When is next earnings date of Resonance Health Ltd(ASX:RHT)?
The next earnings date of Resonance Health Ltd(ASX:RHT) is .
Does Resonance Health Ltd(ASX:RHT) pay dividends? If so, how much?
Resonance Health Ltd(ASX:RHT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Resonance Health Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers